What question did this study set out to answer?

To review the clinical manifestations and molecular mechanisms by which metabolic, electrolyte, and environmental factors alter hERG channel potency and exacerbate drug-induced long QT syndrome.

January 27, 2022Biophysical ReviewsOpen Access

Metabolic and electrolyte abnormalities as risk factors in drug-induced long QT syndrome

View Full Paper

Ask AI

Bookmark

Why the study?

Proarrhythmic risk associated with hERG-blocking drugs can be modified by environmental- and disease-related factors, including febrile temperatures, pH alterations, dyselectrolytaemias, and drug coadministration.

Design

Review

Authors

CTClifford TeBayVictor Chang Cardiac Research Institute AHAdam P. HillVictor Chang Cardiac Research Institute MWMonique J. WindleyVictor Chang Cardiac Research Institute

Discussion

Member takes

Implication

Supports electrolyte monitoring with hERG blockers; extends evidence on modifiable LQTS risk factors but requires prospective validation.

Key Points

To review the clinical manifestations and molecular mechanisms by which metabolic, electrolyte, and environmental factors alter hERG channel potency and exacerbate drug-induced long QT syndrome.
Narrative synthesis of clinical and mechanistic evidence examining factors that influence drug-induced cardiac repolarization prolongation.
Evaluation of environmental and disease-related modulators, including hypokalemia, hypomagnesemia, altered pH, febrile states, and polypharmacy.
Drug-induced long QT syndrome primarily results from pharmacological blockade of the hERG potassium channel conducting the rapid delayed rectifier current (IKr).
Proarrhythmic risk and Torsades de Pointes susceptibility are strongly amplified by patient-specific factors, particularly electrolyte imbalances and altered physiological conditions.

Structured PICO

Population

Patients at risk for drug-induced long QT syndrome (diLQTS)

Intervention

hERG-blocking drugs in the presence of modifying factors (febrile temperatures, pH alterations, hypokalaemia, hypomagnesemia, drug coadministration)

Outcome

Proarrhythmic risk (drug-induced long QT syndrome and torsades de pointes)

This review highlights the critical role of metabolic and electrolyte abnormalities, such as hypokalemia and hypomagnesemia, in exacerbating the risk of drug-induced long QT syndrome and torsades de pointes.

Cite This Study

TeBay et al. (2022) studied this question.

synapsesocial.com/papers/69dabaacaae38ff6ad836253 https://doi.org/10.1007/s12551-022-00929-7

View Full Paper

Ask AI

Bookmark

Metabolic and electrolyte abnormalities as risk factors in drug-induced long QT syndrome

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Metabolic and electrolyte abnormalities as risk factors in drug-induced long QT syndrome

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider